Sanofi-Synthélabo. In 2004, Sanofi-Synthélabo merged with Aventis and renamed to Sanofi-Aventis, which were each the product of several previous mergers...

Wikimedia Commons has media related to Hoechst AG. Archive site Sanofi Aventis site Aventis Foundation Documents and clippings about Hoechst AG in the 20th Century...

national team in November 2022. Aventis Aventisian at Soccerway "AVENTIS AVENTISIAN VERVOLGT VOETBALCARRIÈRE IN KROATIË" [AVENTIS AVENTISIAN CONTINUES FOOTBALL...

Aventis Graduate School is an international graduate business school based in Singapore. It was founded in 2007. Aventis offers postgraduate and doctorate...

In 2004, Aventis merged with and into Sanofi. The new Sanofi-Aventis Group became the world's 3rd largest pharmaceutical company. Aventis Pasteur, the...

Aventi Technology is a Norwegian private company headquartered at Økern in Oslo, Norway. The company specialises in industrial automation and is active...

1997. In 2000 he moved to Aventis in America, becoming chief operating officer of Aventis USA in 2002, which became Sanofi Aventis USA in 2004. He joined...

eased due to the Aventis' testing and buyback program discussed below. In January 2001, under a written agreement with 17 US states, Aventis initiated a program...

December 2022. Pauli, Michelle (13 April 2006). "Diamond in the running for Aventis hat-trick". the Guardian. Retrieved 3 December 2022. Ian, Sample (26 April...

selective CB1 receptor blocker and was discovered and developed by Sanofi-Aventis. On 21 June 2006, the European Commission approved the sale of rimonabant...

Italy) Depakine (Sanofi Aventis France) Depakine (Sanofi Synthelabo Romania) Depalept (Sanofi Aventis Israel) Deprakine (Sanofi Aventis Finland) Encorate (Sun...

assigned to the German pharmaceutical company Hoechst AG (since merged into Aventis) on 29 October 1991. The patent was scheduled to expire on 29 October 2008...

sold the development rights to Hoechst Marion Roussel (now part of Sanofi-Aventis), and was later approved by the U.S. Food and Drug Administration (FDA)...

history 2008–2010 2011 2011–2012 2013– Team Type 1 (TT1) Team Type 1–Sanofi Aventis (TT1) Team Type 1–Sanofi (TT1) Team Novo Nordisk (TNN) Current season...

while Yeda and Sanofi-Aventis co-own the 866 Patent's foreign counterparts. Following the ruling, ImClone and Sanofi-Aventis agreed to settle the dispute...

Assertio Therapeutics, Inc AstraZeneca – AstraZeneca UK Limited Aventis Pharma – Sanofi-Aventis Ltd Bausch & Lomb – Bausch & Lomb UK Ltd Baxter – Baxter International...

merged with Hoechst AG to form Aventis. In 2004, Aventis went on to merge with Sanofi-Synthélabo forming Sanofi-Aventis, the third-largest pharmaceutical...

2014. "Arava (leflunomide) tablet, film coated [sanofi-aventis U.S. LLC]". DailyMed. sanofi-aventis U.S. LLC. November 2012. Retrieved 11 March 2014. "Arava...

medical use in 1998. It is produced and marketed by Warner Chilcott, Sanofi-Aventis, and in Japan by Takeda under the trade names Actonel, Atelvia, and Benet...

which conducts the American business of Aventis Dermatology, the global dermatology unit of Aventis (of Sanofi-Aventis). PLLA was approved by the FDA on August...

23 September 2021. Retrieved 22 February 2021. … Aventis says that it has agreed to sell its Aventis Behring blood products business to Australia's CSL...

Bangladesh) Tricef (by Alkaloid Skopje, North Macedonia) Orelox (by Sanofi-Aventis) MAPDOX-CV: Cefpodoxime and Clavulanic acid combination MONOTAX O (Cefpodoxime)/...

He was the chairman of Sanofi India (previously known as Hoechst AG and Aventis) and the chairman of Bayer CropScience in India for over 20 years, and...

headquartered at La Défense include Neuf Cegetel, Société Générale, TotalEnergies, Aventis, Areva, and Arcelor. The tallest skyscraper, the Tour First belongs to...

pharmaceutical company, Aventis Pharma. (Currently the Indian subsidiary of the global pharmaceuticals major Sanofi-Aventis). UB Group had a relationship...

world production of vitamin B12, by four companies (the French Sanofi-Aventis and three Chinese companies) in 2008 was 35 tonnes. The two bioactive forms...

was developed by Sanofi Research (part of Sanofi-Aventis). It is jointly marketed by Sanofi-Aventis and Bristol-Myers Squibb under the brand names Aprovel...

and the negative symptoms of schizophrenia. It was introduced by Sanofi-Aventis in the 1990s. Its patent expired by 2008, and generic formulations became...

become Sanofi-Synthélabo. Sanofi-Synthélabo merged with Aventis in 2004 to become Sanofi-Aventis. On 17 March 2006, L'Oréal purchased cosmetics company...

with Rhône-Poulenc to become Aventis in 1999 and in 2004 Aventis merged with Sanofi-Synthélabo to become Sanofi-Aventis. In 2005, around 22,000 people...